Increased immunogen valency improves the maturation of vaccine-elicited HIV-1 VRC01-like antibodies.
Antibodies belonging to the VRC01-class display broad and potent neutralizing activities and have been isolated from several people living with HIV (PLWH). A member of that class, monoclonal antibody VRC01, was shown to reduce HIV-acquisition in two phase 2b efficacy trials. VRC01-class antibodies a...
Saved in:
| Main Authors: | Parul Agrawal, Arineh Khechaduri, Kelsey R Salladay, Anna MacCamy, Duncan K Ralph, Andrew Riker, Andrew B Stuart, Latha Kallur Siddaramaiah, Xiaoying Shen, Frederick A Matsen, David Montefiori, Leonidas Stamatatos |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-05-01
|
| Series: | PLoS Pathogens |
| Online Access: | https://doi.org/10.1371/journal.ppat.1013039 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Priming VRC01-precursor B cells with non-envelope immunogens disfavors boosting with HIV-1 envelope
by: Andrew Wilcox-King, et al.
Published: (2025-08-01) -
Improved pharmacokinetics of HIV-neutralizing VRC01-class antibodies achieved by reduction of net positive charge on variable domain
by: Young D. Kwon, et al.
Published: (2023-12-01) -
Analytical treatment interruption among women with HIV in southern Africa who received VRC01 or placebo in the Antibody Mediated Prevention Study: ATI stakeholder engagement, implementation and early clinical data
by: Shelly Karuna, et al.
Published: (2025-06-01) -
Valence (Drôme). Cathédrale Saint-Apollinaire
by: Michel Goy
Published: (2006-11-01) -
Professional Balance and it’s Psychological Valences
by: Mariana ZUBENSCHI
Published: (2017-06-01)